Results

Total Results: 575 records

Showing results for "blood pressure medications".

461. The series of articles beginning with this issue of the Journal form the most up-to-date version of the Guide for Conducting Comparative Effectiveness Reviews (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-principles_methods.pdf
     August 01, 2009 - functional status, or fractures) are emphasized over studies of intermediate outcomes (such as changes in blood … pressure levels or bone density).

462. Closing the Quality Gap Series: End-of-Life and Hospice Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/quality-gap-palliative-hospice/research-protocol
     December 01, 2019 - For example, many types of medications and other interventions to treat pain are supported by strong … improvements in pain-related outcomes such as quality of life. 4 However, studies have found that these medications … Promotion of self-management (workshops and materials such as blood pressure or glucose monitoring devices

463. Labor-Nitrous-Oxide Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
     August 01, 2012 - isoflurane are used for other types of anesthesia in the United States Epidural • Injection of medications

464. FRN 40 - Screening for Methicillin-Resistant Staphylococcus aureus (MRSA): Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
     June 01, 2013 - FRN 40 - Screening for Methicillin-Resistant Staphylococcus aureus (MRSA): Future Research Needs Future Research Needs Paper Number 40 Screening for Methicillin- Resistant Staphylococcus aureus (MRSA): Future Research Needs Future Research Needs Paper Number 40 Screening for Methicillin-Resistant Staph…

465. Omega-3 Fatty Acids and Maternal and Child Health: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
     October 01, 2016 - KQ2) o Diet with different level of Vitamin E exposure • Outcomes: – Maternal outcomes (KQ1) o Blood … pressure control � Incidence of gestational hypertension � Maternal blood pressure � Incidence of

466. Grading the Strength of a Body of Evidence when Comparing Medical Interventions | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-grading-strength/methods
     December 01, 2019 - , potential harms, and for some reviews, intermediate end points or surrogate markers (for example, blood … pressure control or cholesterol levels).

467. Renal-Function Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
     August 01, 2014 - pressure, dyslipidemia, and smoking. … pressure, lipids, and diabetes. … associated with worse outcomes, should these patients be managed differently (i.e., subjected to different medications … Should clinicians prescribe additional preventive medications such as aspirin, statins, or beta-blockers … Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

468. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - studies), (3) heart size (4 studies), (4) pretest probability (3 studies), and (5) use of beta blocker medications … obstructive) in symptomatic patients lead to better implementation of secondary measures—control of blood … pressure, diabetes, and hyperlipidemia—to reduce future cardiac events? … Or is it more important to intervene with medications and/or revascularization when ischemia is present

469. Cystic-Fibrosis-Hgh Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
     August 01, 2012 - CER # 23: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis Original release date: October 2010 Surveillance Report 1st Assessment: November, 2011 Surveillance Report 2nd Assessment: August 2012 Key Findings 1st Assessment: • All conclusions for KQ…

470. Management and Outcomes of Binge Eating Disorder (BED) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/binge-eating/research-protocol
     December 01, 2019 - acid (GABA) receptor agonists, 51,52 and weight loss agents. 53,54 Currently, however, none of these medications … Appetite-regulating peptide hormones Blood lipids (cholesterol, triglycerides) Blood glucose, hemoglobin A1c Blood … pressure Final health outcomes Behavioral Binge eating: frequency of binge episodes,

471. Disposition of Comments: Comparative Effectiveness Review No. 232_Interventions for Breathlessness in Patients With Advanced Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-232-breathlessness-cancer-comments.pdf
     November 19, 2020 - respiratory rate, heart rate, blood pressure, anxiety, HRQOL). … conclusion regarding attribution of side effects if we do not know if the patients received appropriate medications

472. Assessing Applicability (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-applicability.ppt
     January 01, 2009 - Comparing the demographics of patients in a disease registry (age, gender, comorbidities, baseline medications … Similarly, the use of surrogate end points such as blood pressure or cholesterol, instead of health outcomes … In the comparator column, the comparator is described, and then the extent of use of other medications

473. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
     January 01, 2018 - Exclusion of non-antipsychotic medications as comparator. … syndrome, change in body composition, fasting glucose, insulin sensitivity/ resistance, dyslipidemia, blood … pressure • Prolactin-related effects and sexual dysfunction (e.g., hyperprolactinemia, AEs related … Only one study permitted concomitant psychotropic medications including stimulants. … Treatment of young people with antipsychotic medications in the United States.

474. Chapter 9: Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard” | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-performance/methods
     December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

475. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - Helminthic therapy may also compete with over-the-counter drugs and herbal medications, which patients

476. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - However, within‐individual differences in the pharmacodynamic effect of these “similar” medications … If there’s no evidence of a pharmacodynamic effect of these life-saving medications, is it reasonable … Various factors, including the CYP2C19 genotype, concomitant medications, comorbidities, and other factors … The purpose of prescribing P2Y12‐inhibiting antiplatelet medications is to reduce the risk for thrombosis … As previously stated, the purpose of prescribing P2Y12‐ inhibiting antiplatelet medications is to reduce

477. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
     February 23, 2012 - interest include: health outcome measures (e.g. morbidity and mortality, indirect health outcomes such as blood … pressure and HbA1c); process measures (e.g. proportion of patients treated according to clinical guidelines

478. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/attention-deficit-hyperactivity-disorder/protocol
     July 01, 2022 - For Key Question 2, input addressed the importance of reviewing the effects of medications and the risk … appetite, growth suppression, weight decrease, sleep disturbance, gastrointestinal symptoms, elevated blood … pressure, increased heart rate, risk of sudden cardiac death, cardiac arrhythmias, conduction abnormalities … Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long … Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long

479. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
     November 01, 2021 - For Key Question 2, input addressed the importance of reviewing the effects of medications and the risk … appetite, growth suppression, weight decrease, sleep disturbance, gastrointestinal symptoms, elevated blood … pressure, increased heart rate, risk of sudden cardiac death, cardiac arrhythmias, conduction abnormalities … Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long … Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long

480. Closing the Quality Gap Series: Quality Improvement Interventions to Address Health Disparities | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/disparities-quality-improvement/research-protocol
     December 01, 2019 - interest include: health outcome measures (e.g. morbidity and mortality, indirect health outcomes such as blood … pressure and HbA1c); process measures (e.g. proportion of patients treated according to clinical guidelines